RICHARD J WENSTRUP, M.D.
Medical Practice in Cincinnati, OH
License number
Ohio 35-06-5950
Category
Medical Practice
Type
Pediatrics
Address
Address
3333 Burnet Ave Ml, Cincinnati, OH 45229
Phone
(513) 636-4760
(513) 636-7297 (Fax)
(513) 636-4225
(513) 636-2511 (Fax)
(513) 636-7297 (Fax)
(513) 636-4225
(513) 636-2511 (Fax)
Personal information
See more information about RICHARD J WENSTRUP at radaris.comName
Address
Phone
3582 9 Mile Tobasco Rd, Cincinnati, OH 45255
3737 Earls Court Vw, Cincinnati, OH 45226
5755 Windridge Vw APT 63, Cincinnati, OH 45243
5755 Windridge Vw, Cincinnati, OH 45243
Cincinnati, OH
Professional information
Microarray-Based Diagnosis Of Pediatric Hearing Impairment-Construction Of A Deafness Gene Chip
US Patent:
2005011, May 26, 2005
Filed:
Feb 24, 2004
Appl. No.:
10/786518
Inventors:
John Greinwald - Loveland OH, US
Richard Wenstrup - Cincinnati OH, US
Bruce Aronow - Cincinnati OH, US
John Pestian - Loveland OH, US
Richard Wenstrup - Cincinnati OH, US
Bruce Aronow - Cincinnati OH, US
John Pestian - Loveland OH, US
International Classification:
C12Q001/68, C12M001/34
US Classification:
435006000, 435287200
Abstract:
The present invention is related to diagnostic arrays comprising primers for various regions of candidate genes involved in hearing loss, specifically pediatric hearing loss. The invention further is directed to methods for diagnosing a cause or risk factor for hearing loss. In some embodiments, these methods include obtaining a sample from a patient; screening the sample for the presence or absence of alleles of at least 5 loci associated with a risk for hearing loss to obtain a result of the screening; and making a diagnosis based upon the result. The present invention is also directed to the amplification of genetic sequence from multiple or single exons for use in the screening of samples.
Richard Jerome Wenstrup, Cincinnati OH
Specialties:
Pediatrics, Medical Genetics, Clinical Molecular Genetics, Clinical Genetics, M.D., Pediatric Medical Genetics
Work:
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45267
3333 Burnet Ave, Cincinnati, OH 45267
Education:
University of Cincinnati (1978)
Microarray-Based Diagnosis Of Pediatric Hearing Impairment-Construction Of A Deafness Gene Chip
US Patent:
2004016, Aug 26, 2004
Filed:
Feb 24, 2003
Appl. No.:
10/373978
Inventors:
John Greinwald - Loveland OH, US
Richard Wenstrup - Cincinnati OH, US
Bruce Aronow - Cincinnati OH, US
Richard Wenstrup - Cincinnati OH, US
Bruce Aronow - Cincinnati OH, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The present invention is related to diagnostic arrays comprising primers for various regions of candidate genes involved in hearing loss, specifically pediatric hearing loss. The invention further is directed to methods for diagnosing a cause or risk factor for hearing loss. In some embodiments, these methods include obtaining a sample from a patient; screening the sample for the presence or absence of alleles of at least 5 loci associated with a risk for hearing loss to obtain a result of the screening; and making a diagnosis based upon the result.
Dr. Richard J Wenstrup, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics, Clinical Molecular Genetics
Address:
3333 Burnet Ave SUITE 1033, Cincinnati 45229
(513) 636-4760 (Phone), (513) 636-7297 (Fax)
(513) 636-4760 (Phone), (513) 636-7297 (Fax)
Certifications:
Clinical Genetics, 2006, Clinical Molecular Genetics, 2004, Pediatrics, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Cincinnati / Main Campus
Graduated: 1978
Fairview University Med Center
University Wa Med Center
University of Cincinnati / Main Campus
Graduated: 1978
Fairview University Med Center
University Wa Med Center
Diagnostic Assay For Autoimmune Lymphoproliferative Syndrome (Alps) And Genetically Related Disorders
US Patent:
2008009, Apr 17, 2008
Filed:
Oct 13, 2006
Appl. No.:
11/580529
Inventors:
Kejian Zhang - Cincinnati OH, US
Richard J. Wenstrup - Cincinnati OH, US
Jacob J. Bleesing - Cincinnati OH, US
Alexandra H. Filipovich - Covington KY, US
Richard J. Wenstrup - Cincinnati OH, US
Jacob J. Bleesing - Cincinnati OH, US
Alexandra H. Filipovich - Covington KY, US
International Classification:
C12Q 1/68, C07H 21/04, C12P 19/34
US Classification:
435 6, 435 912, 536 231
Abstract:
The methods and compositions of the invention find use in the clinical diagnosis of TNFRSF6-related syndromes, particularly autoimmune lymphoproliferative syndrome (ALPS). The compositions of the invention include isolated nucleic acid molecules and oligonucleotide pairs suitable for use in amplifying regions of the TNFRSF6 gene and in determining the nucleotide sequence of the TNFRSF6 gene in a patient. The invention facilitates efficient, cost-effective amplification of one or more regions of the TNFRSF6 gene. The nucleotide sequence of amplified DNA comprising one or more regions of the TNFRSF6 gene can be determined. Knowledge of the patient's nucleotide sequence in the TNFRSF6 gene allows diagnosis of the patient.
Diagnostic Assay For Wiskott-Aldrich Syndrome And Genetically Related Disorders
US Patent:
2006013, Jun 22, 2006
Filed:
Dec 6, 2005
Appl. No.:
11/295149
Inventors:
Kejian Zhang - Cincinnati OH, US
Richard Wenstrup - Cincinnati OH, US
Alexandra Filipovich - Covington KY, US
Richard Wenstrup - Cincinnati OH, US
Alexandra Filipovich - Covington KY, US
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/04
US Classification:
435006000, 435091200, 536023100
Abstract:
The methods and compositions of the invention find use in the clinical diagnosis of primary immunodeficiencies, particularly Wiskott-Aldrich related syndromes. The compositions of the invention include isolated nucleic acid molecules and oligonucleotide pairs suitable for use in amplifying regions of the Wiskott-Aldrich syndrome protein gene and in determining the nucleotide sequence of the Wiskott-Aldrich syndrome protein gene in a patient. The invention facilitates efficient, cost-effective amplification of one or more regions of the Wiskott-Aldrich syndrome protein gene. The nucleotide sequence of amplified DNA comprising one or more regions of the Wiskott-Aldrich Syndrome Protein gene can be determined using the methods and compositions of the invention. Knowledge of the patient's nucleotide sequence in the Wiskott-Aldrich Syndrome Protein gene allows diagnosis of the patient's primary immunodeficiency.
Optimization And Individualization Of Medication Selection And Dosing
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 14, 2013
Appl. No.:
14/053220
Inventors:
Richard J. Wenstrup - Cincinnati OH, US
Alexander A. Vinks - Cincinnati OH, US
John Pestian - Cincinnati OH, US
Alexander A. Vinks - Cincinnati OH, US
John Pestian - Cincinnati OH, US
International Classification:
G06F 19/00
US Classification:
705 2
Abstract:
The invention provides systems and methods for producing a ranked list of drugs for administration to a patient in need thereof, the ranked list produced by calculating for each drug a score that is the product of a patient vector, a weighting vector, and the drug's column value in a disease matrix.